It’s Not A Fantasy To Think That Silk Road Medical Inc (SILK) Has Big Future Potential

Silk Road Medical Inc (NASDAQ:SILK) currently has a daily average trading volume of 1.84M but it saw 1086309 shares traded in last market. With a market cap of 1.10B USD, the company’s current market price of $27.16 came rising about 0.41 while comparing to the previous closing price of $27.05. In past 52 weeks, the stock remained buoying in the range of price level as high as $27.23 and as low as $6.08. In the recent trading on the day, stock has struck highest price mark of $27.07 while lowest mark touched by it was $27.18.

Taking a look at 20-day trading activity of Silk Road Medical Inc (SILK) gives us an average price of $27.07, while its current price level is -0.26% below from 52-week high level whereas it is 346.71% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $26.53 while that of 200 days or SMA-200 reads an average of $18.23. A closer look into the stock’s movement over the week reveals that its volatility is standing at 0.31% during that period while stretching the period over a month that increases to 0.39%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 64.47 which implies that the stock is in neutral territory.

Argus upgraded its recommendation for the stock as a “Buy” from “Hold” on March 07, 2024 while assigning a price target of $24. Stifel issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $9 and $20.

Over the week, SILK’s stock price is moving 0.15% up while it is 0.41% when we observe its performance for the past one month. Year-to-date it is 121.35% up and over the past year, the stock is showing an upside performance of 25.57%.

Currently, Silk Road Medical Inc’s total number of outstanding shares is 39.17M. Company’s return on investment (ROI) stands at -23.82% and return on equity (ROE) at -36.45%. Stock’s beta reads 1.53. Stock has a price to book (P/B) ratio of 7.13 while price to sale or P/S ratio amounts to 5.76. Its return on asset (ROA) is -21.21% on average.